JPWO2022224980A1 - - Google Patents
Info
- Publication number
- JPWO2022224980A1 JPWO2022224980A1 JP2023515491A JP2023515491A JPWO2022224980A1 JP WO2022224980 A1 JPWO2022224980 A1 JP WO2022224980A1 JP 2023515491 A JP2023515491 A JP 2023515491A JP 2023515491 A JP2023515491 A JP 2023515491A JP WO2022224980 A1 JPWO2022224980 A1 JP WO2022224980A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
- A61K51/1096—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies radioimmunotoxins, i.e. conjugates being structurally as defined in A61K51/1093, and including a radioactive nucleus for use in radiotherapeutic applications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021071320 | 2021-04-20 | ||
| JP2022030389 | 2022-02-28 | ||
| PCT/JP2022/018246 WO2022224980A1 (ja) | 2021-04-20 | 2022-04-20 | 抗cd20抗体の放射性複合体、及び、放射性医薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2022224980A1 true JPWO2022224980A1 (cg-RX-API-DMAC7.html) | 2022-10-27 |
Family
ID=83722303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515491A Pending JPWO2022224980A1 (cg-RX-API-DMAC7.html) | 2021-04-20 | 2022-04-20 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240207464A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4327831A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2022224980A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202306983A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022224980A1 (cg-RX-API-DMAC7.html) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019203191A1 (ja) * | 2018-04-16 | 2019-10-24 | 日本メジフィジックス株式会社 | 修飾抗体、および、放射性金属標識抗体 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736137A (en) | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| CA2494104A1 (en) | 2002-07-31 | 2004-04-22 | Seattle Genetics, Inc. | Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders |
| CA2509103A1 (en) | 2002-12-13 | 2004-07-01 | Mitra Medical Technology Ab | Antilymphoma targeting agents with effector and affinity functions linked by a trifunctional reagent |
| US20050255042A1 (en) * | 2003-11-24 | 2005-11-17 | The Regents Of The University Of California Office Of Technology Transfer, University Of California | On-demand cleavable linkers for radioconjugates for cancer imaging and therapy |
| JP6872181B2 (ja) | 2015-05-20 | 2021-05-19 | 国立大学法人 鹿児島大学 | IgG結合ペプチドによる抗体の特異的修飾 |
| DK3470418T3 (da) | 2016-06-13 | 2024-09-30 | Univ Kagoshima | Site-specifik radioisotop-mærket antistof ved brug af using iggbindende peptid |
| WO2018230257A1 (ja) | 2017-06-16 | 2018-12-20 | 国立大学法人鹿児島大学 | IgG結合ペプチド、及び該ペプチドによる抗体の特異的修飾 |
| JP2021506842A (ja) * | 2017-12-18 | 2021-02-22 | ヤンセン バイオテツク,インコーポレーテツド | ポリペプチドの放射性標識 |
| PH12022550894A1 (en) * | 2019-10-18 | 2023-03-27 | Nihon Mediphysics Co Ltd | Ri-labeled humanized antibody |
| CN114555132A (zh) * | 2019-10-18 | 2022-05-27 | 日本医事物理股份有限公司 | 放射性金属标记抗体的制造方法 |
| JP7680745B2 (ja) | 2019-10-24 | 2025-05-21 | 国立大学法人 鹿児島大学 | 1価ccap生成物の製造方法 |
| JP2021071320A (ja) | 2019-10-29 | 2021-05-06 | 株式会社Gsユアサ | Soh推定装置、蓄電装置及びsoh推定方法 |
| JP7581695B2 (ja) | 2020-08-07 | 2024-11-13 | スズキ株式会社 | リアコンビネーションランプの保護構造 |
| JPWO2023033022A1 (cg-RX-API-DMAC7.html) * | 2021-08-31 | 2023-03-09 |
-
2022
- 2022-04-20 JP JP2023515491A patent/JPWO2022224980A1/ja active Pending
- 2022-04-20 US US18/556,527 patent/US20240207464A1/en active Pending
- 2022-04-20 WO PCT/JP2022/018246 patent/WO2022224980A1/ja not_active Ceased
- 2022-04-20 TW TW111114988A patent/TW202306983A/zh unknown
- 2022-04-20 EP EP22791751.5A patent/EP4327831A4/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019203191A1 (ja) * | 2018-04-16 | 2019-10-24 | 日本メジフィジックス株式会社 | 修飾抗体、および、放射性金属標識抗体 |
Non-Patent Citations (4)
| Title |
|---|
| DAHLE J. ET AL., NUCLEAR MEDICINE AND BIOLOGY, vol. 33, JPN6022029585, 2006, pages 271 - 279, ISSN: 0005874610 * |
| FORRER F. ET AL., THE JOURNAL OF NUCLEAR MEDICINE, vol. 54, no. 7, JPN6022029584, 2013, pages 1045 - 1052, ISSN: 0005874609 * |
| MITRAN B. ET AL., INT. J. CANCER, vol. 145, JPN6022029587, 2019, pages 3347 - 3358, ISSN: 0005874612 * |
| XIE Q. ET AL., MOLECULES, vol. Vol.22, 641, JPN6022029586, 2017, pages 1 - 10, ISSN: 0005874611 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4327831A1 (en) | 2024-02-28 |
| WO2022224980A1 (ja) | 2022-10-27 |
| EP4327831A4 (en) | 2026-02-11 |
| US20240207464A1 (en) | 2024-06-27 |
| TW202306983A (zh) | 2023-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR102020022030A2 (cg-RX-API-DMAC7.html) | ||
| BR102021013306B1 (pt) | Disposição introduzida em forno de pizza, com dispostivo de regulagem de altura da esteira com ajustes gradual escalonado | |
| BR102021010384B1 (pt) | Equipamento para limpeza e/ou teste de bicos injetores com alta pressão | |
| BR102021009961B1 (pt) | Sistema e método para aproveitamento da água de injeção dessulfatada de plataformas marítimas para utilização em squeezes de inibição | |
| BR102021007825B1 (pt) | Equipamento de entretenimento e contemplação visual por cabines rotacionais e com giro radial e axial de 360 graus, para instalação em coberturas de edificações, penhascos ou encostas de elevações geográficas abissais | |
| BR102021006565B1 (pt) | Máquina de acabamento de estradas e método para operar a mesma | |
| BR102021005700B1 (pt) | Selo irregular para redução de ruído em aeronaves | |
| BR102021005383B1 (pt) | Método de perfurar um furo de poço marítimo com circulação reversa de fluido sem uso de tubulares de riser de perfuração | |
| BR102021004908B1 (pt) | Equipamento gerador de dióxido de cloro com processamento em alta pressão em reator com três zonas de operação para tratamento de águas e efluentes | |
| BR102021003589B1 (pt) | Método para fabricar uma estrutura monolítica em formato de caixa para fuselagens e asas de aeronave usando um material prepreg de matriz de polímero reforçada com fibra | |
| BR102021003353B1 (pt) | Aerofólio compósito estrutural, aeronave e método de montagem de um aerofólio compósito estrutural | |
| BR102021000474B1 (pt) | Aparelho de pino de medição, sistema de amortecimento multiator, e, conjunto de amortecedor de impacto | |
| BR102020026775B1 (pt) | Montagem de painel de malha de arame soldado e uma ou mais armações, e parede ou teto reforçado por uma ou mais montagens | |
| BR102020026454B1 (pt) | Membrana de nanocelulose bacteriana e seu uso como bolus em radioterapia | |
| BR102020026302B1 (pt) | Processo de produção de corante natural azul | |
| BR102020023974B1 (pt) | Revestimento de amarras para redução de arrasto longitudinal | |
| BR102020021170B1 (pt) | Composição, formulações orais e uso | |
| BR102020018864B1 (pt) | Grade de ventilação modular | |
| BR102020018483B1 (pt) | Dispositivo mecânico para arraste de cabeçote móvel para realização de furos, alargamentos, roscas com machos por intermédio de automatização em tornos mecânicos horizontais | |
| BR102020010912B1 (pt) | Aparelho compacto de eletrólise de baixo custo | |
| BR102020005641B1 (pt) | Método integrado de cultura do peixe lambari-do-rabo-amarelo, camarão-da-amazônia e o peixe curimbatá | |
| BR102020004560B1 (pt) | Rotor eólico utilizando duplas-pás inteiriças para geração de potência | |
| BR102020003823B1 (pt) | Distribuidor de corretivos, fertilizantes e sementes | |
| JPWO2022211051A1 (cg-RX-API-DMAC7.html) | ||
| JPWO2022080481A1 (cg-RX-API-DMAC7.html) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250408 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260602 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260731 |